Latest news with #Peroxide
Yahoo
23-05-2025
- Business
- Yahoo
Hydrogen Peroxide Airborne Surface Disinfection Market to Reach US$ 3.8 Billion by 2034, Driven by Demand for Advanced Infection Control Solutions
Hydrogen Peroxide Airborne Surface Disinfection Market Outlook 2025-2034 Luton, Bedfordshire, United Kingdom, May 23, 2025 (GLOBE NEWSWIRE) -- The global hydrogen peroxide airborne surface disinfection market is expected to reach approximately $1.5 billion in 2024, and is projected to grow significantly to around $3.8 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of about 10% over the forecast period from 2025 to 2034. Get a Sample PDF Brochure: Hydrogen Peroxide Airborne Surface Disinfection systems utilize vaporized or aerosolized hydrogen peroxide to deliver broad-spectrum antimicrobial action. These systems are capable of uniformly dispersing hydrogen peroxide throughout enclosed environments, effectively eliminating viruses, bacteria, yeasts, and bacterial spores. This technology is increasingly being adopted in healthcare and life sciences settings where stringent disinfection standards are critical. Market Context and Drivers The growth of the HPASD market is supported by broader trends in the medical devices industry and healthcare sector. According to recent research, the global medical devices market reached approximately US$ 603 billion in 2023, with a projected CAGR of 5% over the next six years. Healthcare expenditures globally now account for about 10% of global GDP, a figure that continues to rise due to aging populations, the increasing prevalence of chronic and infectious diseases, and expanding healthcare infrastructure in emerging markets. Key drivers influencing the HPASD market include: Rising awareness of infection prevention and control (IPC) practices Increasing adoption of automated disinfection systems in hospitals and pharmaceutical facilities Technological advancements in aerosolized and vaporized disinfection solutions Heightened demand for decontamination solutions amid global health threats Market Forecast and Regional Outlook The "Hydrogen Peroxide Airborne Surface Disinfection Industry Forecast" report offers in-depth analysis of historical sales trends and detailed projections through 2031. It examines the global market by product type, application, and regional segments, providing insights into emerging opportunities across geographies. Browse full Report - By Application Healthcare FacilitiesHealthcare settings represent a major share of the market, driven by stringent hygiene standards and the critical need for infection control. Hydrogen peroxide is extensively used for disinfecting surgical tools, operating theatres, and patient care areas. The growing adoption of automated hydrogen peroxide vapor systems enhances safety and efficacy, further boosting demand in this segment. Food and Beverage IndustryThis segment is experiencing notable growth due to increasing awareness of hygiene regulations and food safety protocols. Hydrogen peroxide is used for disinfecting processing equipment, storage units, and packaging lines. The push for environmentally friendly and non-toxic disinfectants enhances its appeal in this industry. Pharmaceutical IndustryIn pharmaceutical settings, maintaining sterile environments is paramount. Hydrogen peroxide's broad-spectrum efficacy against pathogens helps facilities meet strict regulatory standards. This makes it a critical component in laboratory and manufacturing area disinfection. Institutional & IndustrialCorporate offices, educational institutions, and industrial complexes are increasingly integrating hydrogen peroxide disinfection systems to maintain hygienic environments. The rise in awareness regarding infection control, especially after the COVID-19 pandemic, has turned this into a high-growth area. ResidentialConsumer awareness about hygiene in household environments is expanding the residential segment. Products formulated with hydrogen peroxide are increasingly preferred for being safe, effective, and eco-friendly alternatives to traditional chemical disinfectants. By Form LiquidThe liquid form dominates the market due to its versatility and ease of use across diverse applications. It is widely adopted for general disinfection tasks, particularly in healthcare, industrial, and residential settings. SolidAlthough a smaller segment, solid hydrogen peroxide products are gaining traction for their storage and transport advantages. These are especially useful where liquid forms are less practical, offering solutions in niche industrial and institutional applications. By Concentration Low Concentration (<10%)Primarily used in household cleaning and consumer products, low-concentration hydrogen peroxide offers a safe solution for everyday disinfection. The rise in demand for mild, non-toxic disinfectants is driving growth in this category. Medium Concentration (10%–35%)This concentration is ideal for professional settings such as hospitals, pharmaceutical plants, and food processing facilities. It offers a balance between potency and safety, making it the most commonly used range across commercial sectors. High Concentration (>35%)Predominantly used in industrial environments, high-concentration hydrogen peroxide serves specialized applications requiring intensive disinfection or bleaching. Its demand is fueled by industries where rigorous contamination control is essential. By Distribution Channel Direct SalesDirect-to-client sales remain important, especially for healthcare and institutional buyers seeking customized solutions and long-term partnerships with manufacturers. Online RetailE-commerce platforms are transforming access to hydrogen peroxide products, particularly in the residential and small business segments. Online availability supports increased market penetration by offering convenience and broad product visibility. Distributors/WholesalersThis traditional channel remains vital for industrial and commercial sectors. Distributors provide logistical support, technical assistance, and localized service, ensuring consistent supply to high-demand markets. By End-User Hospitals and ClinicsA leading end-user group, hospitals rely heavily on hydrogen peroxide for its effectiveness in eliminating a broad range of pathogens, ensuring safe environments for patients and staff. Food Processing UnitsAs regulatory scrutiny increases, food processing units are prioritizing high-performance disinfectants. Hydrogen peroxide is a preferred choice due to its efficacy and compliance with food safety standards. Pharmaceutical ManufacturersPharmaceutical companies consistently use hydrogen peroxide to maintain cleanroom standards and meet global regulatory requirements, ensuring continuous demand. Educational InstitutionsSchools and universities are investing in hygiene infrastructure to prevent outbreaks and ensure the well-being of students and staff. This trend is boosting market growth in this segment. Commercial EstablishmentsHotels, restaurants, and office buildings are adopting robust disinfection protocols to maintain safe and hygienic environments for customers and employees, driving significant adoption of hydrogen peroxide-based products. By Region The market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa, each contributing uniquely to the global growth outlook based on regional healthcare standards, industrial development, and consumer awareness. Competitive Landscape The report profiles key industry players, selected based on market presence, product portfolios, and regional coverage. Leading companies include: Bioquell Steris CURIS System Halosil Shibuya TOMI Allentown Vigitechnics DEVEA SAS AM Instruments Global Solidfog Buy Now : These companies are strategically investing in innovation, expanding geographical footprints, and strengthening product capabilities to capture market share in a rapidly evolving infection control environment. Key Questions Explored in the Report What is the 10-year growth outlook for the Hydrogen Peroxide Airborne Surface Disinfection market? What are the key global and regional drivers of market growth? Which technologies and product types are projected to grow fastest? How do market opportunities vary across end-use industries and regions? What are the major competitive strategies shaping the future of the market? This report is also available in the following languages : Japanese (過酸化水素による空気中表面消毒市場), Korean (과산화수소 공기 중 표면 소독 시장), Chinese (过氧化氢空气表面消毒市场), French (Marché de la désinfection des surfaces par voie aérienne au peroxyde d'hydrogène), German (Markt für luftgetragene Oberflächendesinfektion mit Wasserstoffperoxid), and Italian (Mercato della disinfezione delle superfici aeree con perossido di idrogeno), etc. Get a Sample PDF Brochure: More Related Reports: Magnetic Resonance Image-Guided Focused Ultrasound (MRgFUS) System Market The global Magnetic Resonance Image-Guided Focused Ultrasound (MRgFUS) market is valued at approximately $500 million in 2024 and is projected to reach around $1.5 billion by 2034, reflecting robust growth. The estimated Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is approximately 12.5%. Digital Contraceptive Market The global digital contraceptive market is valued at approximately $3.2 billion, driven by an increasing demand for innovative family planning solutions and improved accessibility of digital health technologies. The market is projected to reach around $8 billion by 2034, indicating substantial growth opportunities in the coming decade. This translates to a robust Compound Annual Growth Rate (CAGR) of about 10.3% from 2025 to 2034. Surgical Slush Unit Market The global surgical slush unit market is valued at approximately $280 million in 2024, with a strong growth trajectory expected over the next decade. By 2034, the market is projected to reach around $460 million, reflecting the increasing demand for advanced surgical techniques and improved patient care. Bipolar Electrosurgery Market The global bipolar electrosurgery market is valued at approximately $2.6 billion in 2024 and is projected to reach around $5.1 billion by 2034, reflecting a robust CAGR of 8.9%. This growth is driven by advancements in surgical techniques, increasing preferences for minimally invasive procedures, and the rising prevalence of chronic diseases requiring surgical intervention. Midstream Urine Collection Kit Market The global midstream urine collection kit market is anticipated to reach a valuation of approximately $1.5 billion in 2024, driven by increasing awareness of hygiene and the growing prevalence of urinary disorders. The forecast from 2025 to 2034 suggests a robust growth trajectory, projecting the market to reach around $3.2 billion by 2034. This translates to a compound annual growth rate (CAGR) of approximately 8.1% over the forecast period. Long Acting Drug Delivery Market The global long-acting drug delivery market is projected to reach a market value of approximately $9.8 billion in 2024, with significant growth anticipated in the following decade. By 2034, the market is expected to expand to around $24 billion, reflecting a robust Compound Annual Growth Rate (CAGR) of 9.2% from 2025 to 2034. At-home Saliva Testing Kit Market The global market for at-home saliva testing kits is valued at approximately $1.2 billion. This segment is projected to reach about $2.8 billion by 2034, reflecting a robust growth trajectory propelled by increasing consumer demand for convenient health diagnostics. The Compound Annual Growth Rate (CAGR) for the period from 2025 to 2034 is estimated at 9.5%, driven by advancements in testing technology and heightened awareness regarding preventive healthcare. Chikungunya Rapid Testing Market The global chikungunya rapid testing market is valued at approximately $150 million, driven by rising incidences of chikungunya in endemic regions and increasing awareness of rapid diagnostic solutions. The market is projected to grow to around $320 million by 2034, reflecting a Compound Annual Growth Rate (CAGR) of approximately 8.1% during the forecast period from 2025 to 2034. Birth Control Wearable Market The global birth control wearable market is estimated to reach a value of $1.2 billion in 2024, driven by increasing consumer awareness and advancement in health technology. Market dynamics indicate a positive growth trajectory, primarily fueled by rising demand for non-invasive contraceptive methods and personalized health monitoring solutions. The market is projected to expand at a compound annual growth rate (CAGR) of 18.2% from 2025 to 2034, potentially reaching $6.5 billion by 2034. Hydrogen Peroxide Airborne Surface Disinfection Market The global hydrogen peroxide airborne surface disinfection market is poised for significant growth, currently valued at approximately $1.2 billion in 2024. This sector is expected to reach an estimated $3.5 billion by 2034, driven by increasing health awareness and rising demand for effective disinfection solutions in sectors such as healthcare, hospitality, and food processing. Skin Barrier Product Market The global skin barrier product market is valued at approximately $5.1 billion, driven by rising consumer awareness regarding skincare health and the significance of maintaining a robust skin barrier. With an increasing number of individuals experiencing skin-related issues, including eczema and dermatitis, there is a growing demand for specialized skin barrier solutions that provide hydration and protection. Post-Surgical Scar Treatment Market The global post-surgical scar treatment market is valued at approximately $8.4 billion in 2024, with expectations to expand significantly, reaching an estimated $14.5 billion by 2034. This growth represents a robust Compound Annual Growth Rate (CAGR) of around 6.1% for the forecast period from 2025 to 2034. Partial Knee Arthroplasty Market The global market for Partial Knee Arthroplasty (PKA) is projected to be valued at approximately $2.3 billion in 2024. With the increasing prevalence of knee osteoarthritis and a growing aging population, the market is expected to experience substantial growth, reaching an estimated value of $4.5 billion by 2034. This represents a robust compound annual growth rate (CAGR) of about 7.0% during the forecast period from 2025 to 2034. Pelvis Compression Plate Market The global market for pelvis compression plates is projected to reach approximately $1.2 billion in 2024, driven by an increasing incidence of orthopedic injuries and advancements in surgical technologies. The market is expected to witness significant growth, with a projected value of around $2.5 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of approximately 7.7% during the forecast period from 2025 to 2034. Pelvis Fixation System Market The global pelvis fixation system market is valued at approximately $3.5 billion in 2024, with expectations to reach around $6.8 billion by 2034, reflecting a robust growth trajectory. This indicates a Compound Annual Growth Rate (CAGR) of approximately 7.1% during the forecast period of 2025 to 2034. Gynecological Surgery Robot Market The global gynecological surgery robot market is valued at approximately $3.2 billion in 2024, with a projected market value reaching $7.5 billion by 2034. This indicates a robust Compound Annual Growth Rate (CAGR) of about 8.9% during the forecast period from 2025 to 2034. Minimally Invasive Surgical Robot Market The global minimally invasive surgical robot market is poised for significant growth, with a current valuation of approximately $13.4 billion in 2024. The market is projected to reach around $30.1 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period from 2025 to 2034. Hospital Stretcher Elevators Market The global market for hospital stretcher elevators is valued at approximately $1.5 billion. This segment is projected to expand significantly, with an estimated market value of $2.9 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period from 2025 to 2034. Instantaneous Safety Gear Market The global market for instantaneous safety gear is valued at approximately $10.5 billion in 2024, with expectations to reach around $18.7 billion by 2034. This growth signifies a compounded annual growth rate (CAGR) of approximately 6.1% over the forecast period from 2025 to 2034. Medical Ice Pack Market The global medical ice pack market is valued at approximately $900 million in 2024, with expectations to reach around $1.4 billion by 2034. This growth trajectory reflects a projected compound annual growth rate (CAGR) of 4.7% over the period from 2025 to 2034. CONTACT: Contact Data Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
06-05-2025
- Business
- Yahoo
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2025 Financial Results on May 8, 2025
TOMI Environmental Solutions, Inc. FREDERICK, Md., May 06, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ('TOMI') (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the first quarter ended March 31, 2025, after the close of the financial markets on Thursday, May 8, 2025, and will hold a conference call at 4:30 p.m. ET that day. To participate in the call by phone, dial (877) 545-0320 approximately five minutes prior to the scheduled start time and provide participant access code 616069, or request the "TOMI Environmental Solutions fourth quarter earnings call." International callers please dial (973) 528-0002. To access the live webcast or view the press release, please visit the Investor Relations section of the TOMI website or register at the following link: A replay of the teleconference will be available until Thursday, May 22, 2025, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use replay access code: 52458. A replay of the webcast will be available for at least 90 days on the company's website, starting approximately one hour after the completion of the call. TOMI™ Environmental Solutions, Inc.: Innovating for a safer world® TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology ® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments. For additional information, please visit or contact us at info@ Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management's judgment, beliefs, current trends, and anticipated product performance. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements involve a number of risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond our control. As such, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Important factors that could affect our performance and cause results to differ materially from management's expectations are described in the section entitled 'Risk Factors,' in our Annual Report on Form 10-K and other SEC filings. These factors include: our history of losses that may prevent us from achieving profitability in the future; our lack of long-term customer contracts and our inability to rely on our sales history or backlog as an indicator of our future sales; that we are subject to a variety or risks associated with doing business internationally; our success in business depends on our ability to adequately protect our intellectual property; and that our stock price is volatile and there is a limited market for our shares. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
Yahoo
17-03-2025
- Business
- Yahoo
ACM Research (NasdaqGM:ACMR) Stock Soars 91% With Strong Earnings Performance
ACM Research recently experienced a significant stock price increase of 91% over the last quarter, which can be attributed to several key developments. The company reported strong earnings for the year ending 2024, with a notable increase in sales and net income, alongside an improved EPS, which likely bolstered investor confidence. Additionally, ACM's product-related advancements, particularly the qualification of its Single-Wafer High-Temperature Sulfuric Peroxide Mixture tool by a major Chinese manufacturer, marked a significant milestone in their semiconductor manufacturing technology efforts. During this period, overall market conditions were mixed, with the Nasdaq declining amidst a broader market struggle to rebound from a recent sell-off. Despite this volatile backdrop, ACM's robust financial performance and innovative product announcements played a central role in driving its impressive quarterly stock price performance, distinguishing it amid broader market challenges. Evaluate ACM Research's prospects by accessing our earnings growth report. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 23 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. The past five years have witnessed ACM Research's impressive total shareholder return of 233.87%. This growth, though eclipsing recent market struggles, showcases the sound strategic moves by ACM in bolstering its position in the global semiconductor arena. Consistent earnings growth has been a standout feature during this period, with a substantial average annual increase of 37.8%, underpinned by ACM's advances in specialized semiconductor tools. A notable breakthrough came with the Ultra C Tahoe Cleaning tool released in early November 2024, which introduced advanced capabilities to significantly reduce chemical use, highlighting ACM's commitment to efficiency and innovation. The company's addition to the Russell 2000 Defensive Index in July 2024, alongside mixed index removals, supported its longer-term performance trajectory. Despite underperforming the broader US market and the semiconductor sector in the last year, ACM's forecasted revenue growth remains robust, slated to outpace market averages. This, coupled with the company's undervaluation relative to its industry, suggests that ACM's trajectory continues to appeal to investors seeking growth in the semiconductor field. Are you invested in ACM Research already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGM:ACMR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
14-03-2025
- Health
- Yahoo
Several kinds of acne products recalled over cancer risk, FDA says
Several types of skincare products used to treat acne have been recalled due to a cancer risk. The products, which contain benzoyl peroxide, a common treatment for acne, were tested for elevated levels of benzene, the U.S. Food and Drug Administration (FDA) said in a notice this week. The recalled products include: La Roche-Posay Effaclar Duo Dual Action Acne Treatment - lot number MYX46W Walgreens Acne Control Cleanser - lot number 23 09328 Proactiv Emergency Blemish Relief Cream Benzoyl Peroxide 5% - lot number V3305A; V3304A Proactiv Skin Smoothing Exfoliator - lot number V4204A SLMD Benzoyl Peroxide Acne Lotion - lot number 2430600 Walgreens Tinted Acne Treatment Cream - lot number 4970743 Fda Recalls Common Chinese Food Ingredient After Undeclared Sulfites Found In Florida Inspection The manufacturer of Zapzyt Acne Treatment Gel also agreed to voluntarily recall the product because of an elevated level of benzene found in its own testing, the FDA said. The FDA explained that 90% of the 95 products with benzoyl peroxide that were tested had "undetectable or extremely low levels of benzene." Read On The Fox News App Benzene is a "chemical used in the production of a wide range of industrial products, including chemicals, dyes, detergents, and some plastics," according to the agency. Fewer Food Recalls Yet More Americans Sickened In 2024 Than Previous Year, Says New Report It is released into the air through "cigarette smoke, emissions from automobiles, and burning coal and oil." While it is safe to use benzoyl peroxide in acne products, benzene contamination in small amounts over a long period of time "can decrease the formation of blood cells. Long-term exposure to benzene through inhalation, oral intake, and skin absorption may result in cancers such as leukemia and other blood disorders." The FDA said it started independent testing of benzoyl peroxide products after third-party test results "raised concerns about elevated levels of benzene in certain acne products." "FDA testing results indicate fewer products with benzene contamination than the third-party findings," the agency added. The FDA said the companies had voluntarily recalled the products, noting it was at the retail and not the consumer level. "This means retailers are instructed to remove products from store shelves and online marketplaces but does not specifically instruct consumers to take actions regarding products currently in their possession," the FDA said. "Even with daily use of these products for decades, the risk of a person developing cancer because of exposure to benzene found in these products is very low."Original article source: Several kinds of acne products recalled over cancer risk, FDA says
USA Today
14-03-2025
- Health
- USA Today
Acne treatments from brands such as Walgreens, La Roche-Posay, Proactiv are being recalled
Acne treatments from brands such as Walgreens, La Roche-Posay, Proactiv are being recalled Show Caption Hide Caption Carcinogenic chemical found in popular acne creams The safety of skin care has come under scrutiny as elevated levels of the carcinogen benzene have been found in acne creams. unbranded - Newsworthy Some popular skin care products are being voluntarily recalled because they may contain elevated levels of a chemical that causes cancer, according to a notice posted this week by the U.S. Food and Drug Administration (FDA). According to details published online Tuesday by the FDA, six products containing benzoyl peroxide are being recalled after health officials initiated independent testing and found elevated levels of benzene in some acne products containing benzoyl peroxide. A known human carcinogen, benzene is formed in nature and from human activities. Exposure to it can increase the risk of cancer. Among six products being pulled from shelves are Walgreens Acne Control Cleanser and Proactiv Skin Smoothing Exfoliator. The FDA said it has instructed retailers to remove products from store shelves and online marketplaces. "Even with daily use of these products for decades, the risk of a person developing cancer because of exposure to benzene found in these products is very low," the FDA wrote in its post. Here's what to know about the recall: What cancer did Rep. Raul Grijalva have? Longtime congressman from Arizona dies at 77 Which acne treatments are being recalled? The recalled products carry the following lot number and expiration date: La Roche-Posay Effaclar Duo Dual Action Acne Treatment; Lot number: MYX46W; Expiration date: April 2025 Proactiv Emergency Blemish Relief Cream Benzoyl Peroxide 5%: Lot numbers V3305A and V3304A; Expiration date: October 2025 Proactiv Skin Smoothing Exfoliator: Lot number: V4204A; Expiration date: July 2025 Walgreens Acne Control Cleanser: Lot number: 23 09328; Expiration date: September 2025 Walgreens Tinted Acne Treatment Cream: Lot number: 49707430; Expiration date: March 2026 SLMD Benzoyl Peroxide Acne Lotion: Lot number: 2430600; Expiration date: April March 2025 In addition, the FDA reported, the manufacturer of another benzoyl peroxide acne product, Zapzyt Acne Treatment Gel, agreed to voluntarily recall the product due to the elevated level of benzene found during its own testing. The FDA did not provide the lot number for that product but anyone who bought it should throw it away. What is benzene? Benzene is a chemical. It is a colorless or light-yellow flammable liquid also used to make dyes, detergents, plastic, pesticides and rubber, according to the Centers for Disease Control and Prevention (CDC). It is also a natural part of crude oil, gasoline and cigarette smoke. A major health effect of the carcinogen's long-term exposure is on the blood, according to federal health officials. The Department of Health and Human Services has linked long-term benzene exposure in the air to causing leukemia. More recalls: Nasal wash recalled nationwide over bacteria risk: What to know What should I do if I bought the recalled acne treatments? Consumers who purchased the product and used it should contact their health care provider as a precaution, according to the FDA. Contributing: Kathleen Wong Natalie Neysa Alund is a senior reporter for USA TODAY. Reach her at nalund@ and follow her on X @nataliealund.
